As the landscape of obesity treatment evolves, the intersection of pharmacologic therapies and surgical options becomes increasingly nuanced. In this episode, Dr. Janey Pratt and I explore when and how glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) can be used in relation to bariatric surgery. We discuss surgical candidacy criteria, benefits of bariatric surgery, long-term outcomes, and how to match treatment strategies to patient-specific characteristics, preference